Success Stories: A Visiting Scientist Achieves EB1A Case Approval With the Help of Our Assistance in Just 6 days

Posted by wegreened on November 18, 2024 in EB1 Green Card, Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology)

Client’s Testimonial:

“Sure, I am so glad to receive this news and surely would like to share this success. Thank you all!”

On March 28^th, 2023, we received another EB-1A (Alien of Extraordinary Ability) approval for a Visiting Scientist in the Field of Gynecology (Approval Notice).

General Field: Gynecology

Position at the Time of Case Filing: Visiting Scientist

Country of Origin: China

State of Residence at the Time of Filing: Maryland

Approval Notice Date: March 28^th, 2023

Processing Time: 6 days (Premium Processing Requested)

Case Summary:

A Visiting Scientist contacted our law firm to help her establish her significant contributions to the U.S. by filing for an EB-1A (Alien of Extraordinary Ability) petition. We presented her exceptional professional background and unparalleled experience important to her current and future work at the USCIS.

Upon reviewing her credentials, we found that our client has a Ph.D. in gynecologic oncology and has accomplished a great publication record in her field. Her research resulted in:

27 peer-reviewed scientific articles and 11 book chapters and these papers have been published in some of the most discerning, high-impact journals in her field.
She has conducted at least 27 reviews for journals to date and her work has been cited by other scholars in numerous published articles as well.
According to Google Scholar, her work has been cited a total of 237 times in at least 21 countries.
Her study has received funding from the National Natural Science Foundation of China and the Guangdong Province Natural Science Grant. Therefore, her research advances work relating to natural and biological processes in the human body.

Furthermore, she is one of the few leading tumor biology and clinical research experts in gynecology and has achieved a consistent and notable record of success and influence in these areas of study. She is especially well-known for determining cofactors between human papillomavirus (HPV) and cervical cancer, as well as the tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer, which has gone on to greatly influence the research of other scientists in the field.

Her case was further supported by including four recommendation letters that she obtained from her fellow experts in the field. One of the recommenders stated:

“[Client’s] research on life-threatening gynecologic tumors certainly benefits the United States…With her research, [Client] has provided new insight into the efficacy of specific treatments and recurrence rates for these diseases. These findings provide essential information for caregivers and patients as they navigate decision-making related to treatments for uterine leiomyosarcoma and ICLM. It is clear from this assessment that [Client’s] research is of great significance to the United States.”

Our team’s efforts successfully paid off in conveying to the USCIS that our client’s expansive experience in the field has afforded her vast knowledge and formidable skills, which are a significant asset to any research setting and thus set her apart as an essential researcher in her field of expertise today.

Thanks to the Premium Processing service upgrade for her EB1A case, it was adjudicated in only 6 days. We wish her to receive her green card as soon as possible.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%